303 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am
and access capital to advance our KL4 surfactant pipeline and build shareholder value. The most advanced programs from our KL4 surfactant pipeline have … in substantial equity dilution; the risk that Discovery Labs will not be able to access credit from its committed equity financing facilities
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
8 May 09
Discovery Labs to Raise $11.3 Million in Registered Direct Offering
12:00am
could result in substantial equity dilution; the risk that Discovery Labs will not be able to access credit from its committed equity financing … facilities, or that the share price at which Discovery Labs may access the facilities from time to time will not enable Discovery Labs to access the full
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
; the Company’s ability to access the debt or equity markets; the Company’s ability to manage costs and execute on its operational and budget plans … on the Company’s operations, including through disruption in supply chain or access to potential international clinical trial sites, and through disruption
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
market. Our top priority is to secure strategic alliance partners and access capital to advance our pipeline and build shareholder value. As we move … that Discovery Labs will not be able to access credit from its committed equity financing facilities, or that the share price at which Discovery Labs may
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
21 Apr 06
Discovery Labs Secures $50 Million Committed Equity Financing Facility
12:00am
potential advantages over our 2004 CEFF, including an adjusted minimum stock threshold price which gives us the ability, once effective, to access capital … to access other traditional financing structures, we believe we are in a position to make strategic financing decisions in support of the Company’s plans
8-K
EX-99.1
fiva5u
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
k3eny1m1p57l
11 Sep 09
Other Events
12:00am
8-K
EX-99.1
d0hs0cu
5 Dec 22
Other Events
7:48am
8-K
EX-99.1
kz2ehueq d0ore
12 May 09
Other Events
12:00am
8-K
EX-99.1
3zuw djdqmlmauyg
11 Aug 22
Windtree Therapeutics Reports Second Quarter 2022 Financial Results and Provides Key Business Updates
4:06pm
8-K
EX-10.1
a515lxs8qncf3rpz21h8
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
73w0d5
29 Apr 09
Discovery Labs Reports First Quarter 2009 Financial Results
12:00am
8-K
EX-99.1
6ok4o2sb7
14 Nov 22
Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
7:33am
8-K
EX-99.1
g7fhw2
26 Feb 10
Discovery Labs Announces Completion of
12:00am
8-K
EX-99.1
deaduq05mg52g s7ia
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
8-K
EX-99.1
t7uu4qy195r
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-99.1
19q8s7pw
5 May 22
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
4:04pm
8-K
EX-99.1
ufgvy 2ckb
23 Aug 22
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF® Global License Agreement
8:30am
8-K
EX-99.1
yo9qdr4xgp8ni6
15 Dec 08
Discovery Labs Secures $25 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
p6jiwh9
28 May 08
Discovery Labs Secures $60 Million Committed Equity Financing Facility
12:00am